デフォルト表紙
市場調査レポート
商品コード
1008533

世界の術中放射線療法(IORT)市場:2021年~2028年

Global Intraoperative Radiation Therapy Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
世界の術中放射線療法(IORT)市場:2021年~2028年
出版日: 2021年06月01日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

術中放射線療法(IORT)は、手術によって行われる集中的な放射線治療で、周囲の正常な組織を温存しながら、標的部位に直接放射線を照射するものです。術中放射線療法(IORT)は、手術で切除しにくい腫瘍がある場合や、小さな腫瘍が残る場合に用いられます。

当レポートでは、世界の術中放射線療法(IORT)市場を調査し、市場の概要、セグメント・地域別の市場規模および成長率の推移と予測、新型コロナウイルス感染症(COVID-19)の影響分析、市場成長の促進要因および抑制要因の分析、市場機会、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

  • 市場内訳:製品・サービス別
  • 市場内訳:技術別
  • 市場内訳:用途別
  • 市場内訳:エンドユーザー別
  • 市場内訳:地域別

第4章 市場力学

  • 市場影響要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 業界分析

  • ファイブフォース分析
  • 疫学分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 新型コロナウイルス感染症(COVID-19)の影響分析

  • 新型コロナウイルス感染症(COVID-19)の影響分析
    • コロナ以前の市場シナリオ
    • 現在の市場シナリオ
    • コロナ以降の市場シナリオ
  • コロナ渦中の価格動向
  • 需給スペクトラム
  • コロナ渦中の市場に対する政府イニシアチブ
  • メーカーの戦略的イニシアチブ
  • 総論

第7章 世界の術中放射線療法(IORT)市場:製品・サービス別

  • イントロダクション
    • 市場規模・前年比成長率の分析:製品・サービス別
    • 市場魅力指数:製品・サービス別
  • 製品
    • イントロダクション
    • 市場規模・成長率の分析
  • システム・アクセレレーター
  • アプリケーター・アフターローダー
  • 治療計画システム
  • 付属品
  • サービス

第8章 世界の術中放射線療法(IORT)市場:技術別

  • イントロダクション
    • 市場規模・前年比成長率の分析:技術別
    • 市場魅力指数:技術別
  • 電子線照射療法
    • イントロダクション
    • 市場規模・成長率の分析
  • 術中近接照射療法

第9章 世界の術中放射線療法(IORT)市場:用途別

  • イントロダクション
    • 市場規模・前年比成長率の分析:用途別
    • 市場魅力指数:用途別
  • 乳がん
    • イントロダクション
    • 市場規模・成長率の分析
  • 脳腫瘍
  • 消化器がん
  • 頭頸部がん
  • 子宮内膜がん・子宮頸がん
  • 肺がん
  • その他

第10章 世界の術中放射線療法(IORT)市場:エンドユーザー別

  • イントロダクション
    • 市場規模・前年比成長率の分析:エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 病院
    • イントロダクション
    • 市場規模・成長率の分析
  • 診療所
  • 外来外科センター

第11章 世界の術中放射線療法(IORT)市場:地域別

  • イントロダクション
    • 市場規模の分析・前年比成長率:地域別
    • 市場魅力指数:地域別
  • 北米
    • イントロダクション
    • 市場力学
    • 市場規模・前年比成長率:製品・サービス別
    • 市場規模・前年比成長率:技術別
    • 市場規模・前年比成長率:用途別
    • 市場規模・前年比成長率:エンドユーザー別
  • 欧州
    • イントロダクション
    • 市場力学
    • 市場規模・前年比成長率:製品・サービス別
    • 市場規模・前年比成長率:技術別
    • 市場規模・前年比成長率:用途別
    • 市場規模・前年比成長率:エンドユーザー別
  • 南米
    • イントロダクション
    • 市場力学
    • 市場規模・前年比成長率:製品・サービス別
    • 市場規模・前年比成長率:技術別
    • 市場規模・前年比成長率:用途別
    • 市場規模・前年比成長率:エンドユーザー別
  • アジア太平洋
    • イントロダクション
    • 市場力学
    • 市場規模・前年比成長率:製品・サービス別
    • 市場規模・前年比成長率:技術別
    • 市場規模・前年比成長率:用途別
    • 市場規模・前年比成長率:エンドユーザー別
  • 中東・アフリカ
    • イントロダクション
    • 市場力学
    • 市場規模・前年比成長率:製品・サービス別
    • 市場規模・前年比成長率:技術別
    • 市場規模・前年比成長率:用途別
    • 市場規模・前年比成長率:エンドユーザー別

第12章 競合情勢

  • 主な戦略・発展動向
  • 企業シェア分析
  • 製品ベンチマーク
  • 主な注目企業
  • 破壊的技術を有する企業
  • スタートアップ企業

第13章 企業プロファイル

  • Carl Zeiss AG
    • 企業概要
    • 製品ポートフォリオ
    • キーハイライト
    • 財務情勢
  • Ariane Medical Systems Ltd
  • Eckert & Ziegler
  • Elekta AB
  • GMV
  • Elekta AB(pub)
  • Xoft Xinjiang Ke LAN Shuang Yi Medical Technology Stock Co., Ltd
  • E-tech Industry CO., Ltd
  • Derma Optic and Electronic Technique Co. Ltd
  • Xinjiang Ke Lan Shuang Yi Medical Technology Stock Co., Ltd,

第14章 DataM Intelligenceについて

目次

Market Overview

The global intraoperative radiation therapy market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Intraoperative radiation therapy (IORT) is an intensive radiation therapy that is administered through surgery. IORT allows direct radiation to the target area while sparing normal surrounding tissue. IORT is used to treat cancers that are difficult to separate during surgery and when there is a concern that microscopic amounts of cancer may remain.

Market Dynamics

The major factors driving the growth of this market are the increase in the predominance rate of cancer across the globe and demand for highly efficient radiation therapy systems for cancer treatment and new product approvals as radiation therapy is used in nearly 50% of all cancer treatments.

The rising incidence of cancer across the globe will drive the market growth

The increasing number of cancer cases such as breast cancer, prostate cancer, and lung cancer globally is expected to fuel the market's growth over the forecast period. As per the World Health Organization, in 2018, approximately 9.6 million deaths recorded over the globe were due to cancer. Furthermore, the National Cancer Institute prognosticated that in 2018, around 1,735,350 new cancer cases would be diagnosed in the US. Additionally, lung cancer is expected to increase the number of new cancer rate cases by 439.2 per 100,000 cases per year.

About 1.9 million new cancer cases and 693,000 cancer deaths were reported in 2018 in North America. Prostate cancers are the most generally diagnosed cancers amongst males in North America. However, breast cancer remains leading cancer in females. As per the American Cancer Society estimates, breast cancer is the most prevalent type of cancer in the US as it caused morbidity in 234,087 people and led to 41,904 deaths in 2018.

Cancer usually develops in older people. 87% of all cancers in the United States are diagnosed in people 50 years or older. Certain behaviors also increase risk, such as eating an unhealthy diet or not being physically active. In the US, approximately 40 out of 100 men and 38 out of 100 women will develop cancer during their lifetime.

Growing applications of IORT in the treatment of cancer is driving the market growth

An increase in the need for highly effective radiation therapy systems for cancer therapy and new product endorsements are projected to increase the intraoperative radiation therapy market during the forecast period. IORT has found essential applications as breast-conserving surgery. Technological advancements in this field, linked with the growing applications of IORT, have appeared in the increasing collaboration among many manufacturers and research institutes to administer clinical trials to study the applicability and efficacy of IORT for different cancer types. The primary aim of these clinical trials is to investigate and evaluate the usefulness of IORT treatment over various cancer applications.

For instance, in 2019, IntraOp Medical, Inc. collaborated with the Massachusetts General Hospital, initiated a study to investigate the effectivity of electron beam intraoperative radiation therapy following chemoradiation in patients with pancreatic cancer.

Shortage of well-trained and skilled oncologists will hamper the market

A high level of precision is needed to achieve maximum tumor control and assure minimal risk to normal tissue at each step of the process. Procedural errors can occur due to interconnectivity problems between different therapy planning and delivery and monitoring systems, increasing patient risks. These complexities incorporated with IORT pose a difficulty towards its widespread appropriation in cancer treatment is seen frequent due to the shortage of well-trained and skilled oncologists.

Industry Analysis

PEST Analysis:

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted the healthcare systems globally and also has a notable impact on the market. As per the article written in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that while the COVID-19 pandemic, there was a 46% reduction in the surgery of the six most prevalent cancer types including lung cancer. Additionally, the Centers for Disease Control and several medical professional organizations suggested that cancer screening and other health prevention services be postponed except the risks outweighed the benefits and ensure the hospital infrastructure for the treatment of COVID-19 patients. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Electron IORT segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Electron intraoperative radiation treatment utilizes electron radiation straight to the residual tumor or tumor bed while cancer surgery. Electron beams are suitable for intraoperative radiation therapy, as the dose falls off rapidly after the target site depending on the electron energy, therefore, forgiving underlying healthy tissue. One of the advantages of IORT is given at the time of operation when microscopic residual tumor cells are most vulnerable to destruction. IORT is also often used in combination with external beam radiotherapy (EBRT), resulting in less necessary doses and shorter treatment times.

Moreover, Cancer Research UK suggests that the population experiencing cancer is expected to increase in the future. As per the report, if current trends in the incidence of vital cancers and population growth are harmonious, it is predicted that there will be 27.5 million new cancer cases worldwide each year by 2040. Thus, this is an expansion of 61.7% from 2018 (17 million). Hence, with the growing prevalence of cancer globally, the requirement for novel therapies, like IORT, and their advantages over conventional methods, are supposed to increase if the awareness concerning these techniques increases.

Lung Cancer segment are expected to dominate the intraoperative radiation therapy market, by application, during the forecast period

Lung cancer still caused more deaths in 2017 than breast, prostate, brain colorectal cancers joined. The mortality drops were also dramatic for melanoma of the skin in the viewing of US Food and Drug Administration approval of novel therapies for metastatic disorder, escalating to 7% annually during 2013 into 2017 from 1% during 2006 by 2010 in men and women aged 50 to 64 years and from 2% to 3% in those aged 20 to 49 years; annual declines of 5% to 6% in people aged 65 years and older are especially striking because rates in this age group were rising before 2013. Thus growing casses of lung cancer will drive the market growth in the forecast priod.

Geographical Analysis

North America region holds the largest market share in the global Intraoperative Radiation Therapy Market

North America region is dominating the global intraoperative radiation therapy market accounted for the largest market share in 2020, owing to the growing incidence of lung cancer in the region, the presence of key market players, and the launch of new commodities influence market growth in the region.

According to the American Cancer Society's estimation, the new lung cancer cases in the United States for 2018 were around 234,030, and about 154,050 deaths were expected due to lung cancer. In the United States, lung cancer survival has been improved, and the incidence of localized lung cancer has increased.

As per the American Lung Association (2018), approximately 541,000 Americans living today have been diagnosed with lung cancer at some point in their lives. The majority of lung cancer patients have been diagnosed within the last five years. Each year, tens of thousands of people are cured of non-small cell lung cancer (NSCLC) in the United States. Lung cancer is primarily a disease of the elderly. It indicates the burden of lung cancer in this country, resulting in the market's growth as there is a high demand for cancer treatment in the United States. Furthermore, associations such as the American Society for Radiation Oncology (ASTRO) have advocated the use of low-energy IORT, which has contributed to its increased adoption in North America.

Competitive Landscape

The intraoperative radiation therapy market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Carl Zeiss AG, Ariane Medical Systems Ltd, Eckert & Ziegler, Elekta AB, GMV, Elekta AB (pub), iCAD Inc., Moffitt Cancer Center, Xoft, Xinjiang Ke LAN Shuang Yi Medical Technology Stock Co., Ltd, E-tech Industry CO., Ltd, Derma Optic and Electronic Technique Co., Ltd, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Intraoperative Radiation Therapy Market globally.

Intraoperative Radiation Therapy Market Key Companies to Watch

Ariane Medical Systems.

Overview: Ariane Medical Systems was incorporated in 2005. Since then, we have worked alongside our clinical partners to optimize the delivery of low-energy X-rays to accessible tumors. The Papillon 50 X-ray brachytherapy system was developed for the treatment of lower rectal cancers. The Papillon 50 is now treating patients in Denmark, France, Sweden, Switzerland and the UK.

Product Portfolio: The Company offers low cost, mobile, treatment delivery system, rectal treatment, intraoperative treatment, skin cancer treatments and other.

Why Purchase the Report?

  • Visualize the composition of the intraoperative radiation therapy market segmentation by product and service, technology, application and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in intraoperative radiation therapy market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of intraoperative radiation therapy market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global intraoperative radiation therapy market report would provide an access to an approx. 58 market data table, 61 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Intraoperative Radiation Therapy Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Intraoperative Radiation Therapy Market - Market Definition and Overview

3. Global Intraoperative Radiation Therapy Market - Executive Summary

  • 3.1. Market Snippet by Product and Service
  • 3.2. Market Snippet by Technology
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Global Intraoperative Radiation Therapy Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising incidence of cancer across the globe will drive the market growth
      • 4.1.1.2. Growing applications of IORT in the treatment of cancer is driving the market growth
    • 4.1.2. Restraints:
      • 4.1.2.1. Shortage of well-trained and skilled oncologists will hamper the market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Intraoperative Radiation Therapy Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Intraoperative Radiation Therapy Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Intraoperative Radiation Therapy Market - By Product and Service

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Service Segment
    • 7.1.2. Market Attractiveness Index, By Product and Service Segment
  • 7.2. Products*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Systems/Accelerators
  • 7.4. Applicators & Afterloaders
  • 7.5. Treatment Planning Systems
  • 7.6. Accessories
  • 7.7. Services

8. Global Intraoperative Radiation Therapy Market - By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Electron IORT*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Intraoperative Brachytherapy

9. Global Intraoperative Radiation Therapy Market - By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Breast Cancer*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Brain Tumor
  • 9.4. Gastrointestinal Cancer
  • 9.5. Head & Neck Cancer
  • 9.6. Colorectal Cancer
  • 9.7. Endometrial & Cervical Cancer
  • 9.8. Lung Cancer
  • 9.9. Other

10. Global Intraoperative Radiation Therapy Market - By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Centers

11. Global Intraoperative Radiation Therapy Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Service
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Service
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Service
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Service
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Service
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Intraoperative Radiation Therapy Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. Key Companies to Watch
  • 12.5. Company with disruptive technology
  • 12.6. Start Up Companies

13. Global Intraoperative Radiation Therapy Market- Company Profiles

  • 13.1. Carl Zeiss AG*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview.
  • 13.2. Ariane Medical Systems Ltd
  • 13.3. Eckert & Ziegler
  • 13.4. Elekta AB
  • 13.5. GMV
  • 13.6. Elekta AB (pub)
  • 13.7. Xoft Xinjiang Ke LAN Shuang Yi Medical Technology Stock Co., Ltd
  • 13.8. E-tech Industry CO., Ltd
  • 13.9. Derma Optic and Electronic Technique Co. Ltd
  • 13.10. Xinjiang Ke Lan Shuang Yi Medical Technology Stock Co., Ltd,

LIST NOT EXHAUSTIVE

14. Global Intraoperative Radiation Therapy Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us